China, the National Medical Products Administration (NMPA), announced the <Cosmetics Inspection and Management Methods> on April 29, 2024, to strengthen supervision and standardize the inspection of cosmetics and implemented it on November 1, 2024.
The key points of the Cosmetics Inspection and Management Methods are as follows:
1) Inspection Subjects:
- Cosmetics manufacturers, operators, and other relevant entities and individuals subject to inspection.
2) Classification of Cosmetics Inspections
| Licensing Inspection | An inspection conducted during the cosmetics production licensing process to verify if the applicant meets the legal and regulatory requirements. The inspection follows the <Inspection Points and Judgement Principles for Cosmetics Production Quality Management Standards>, and a field inspection of all items is carried out. |
| Regular Inspection | Inspections to verify compliance with the laws and regulations related to cosmetics supervision and management, mandatory national standards, technical specifications, and technical requirements outlined in cosmetics registration or filing materials. Regular inspections focus on children’s cosmetics, special cosmetics, cosmetics using new raw materials, as well as cosmetics registrants, filers, and contract manufacturers. |
| Cause-based Inspection | Inspections based on findings from registration, sample testing, adverse reaction monitoring, risk monitoring, complaints, case investigations (such as violations of cosmetics-related laws), and public opinion monitoring. |
3) Inspection Methods
- On-site inspection
: This is the main inspection method. It can be conducted with or without prior notice after giving notice to the inspected party.
- Non-on-site Inspection
: Inspections based on documents submitted by the inspected party, including remote inspections using digital technologies.
4) Inspection Results
The drug supervision and administration departments and inspection agencies may take appropriate actions such as issuing rectification orders, production and operation suspension orders, recall orders, investigations, and responsibility interviews within a certain period.
Please refer to the attached document below.
If you have any questions about medical device,
please contact us with the below.
ra@jnmglobal.net
info@jnmglobal.net